Life Sciences Training Course Calendar

Back to details

Training format

Topic

Our Life Sciences calendar for the next 12 months:

Live online Classroom 2024 2025
Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun
A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products Regulatory Affairs 5 1
A Practical Approach to Veterinary Vaccine Development and Registration in the EU Regulatory Affairs 11-12 13-14
A Practical Guide to Producing and Maintaining the PSMF Vigilance 5 10 14 23
A Practical Guide to Writing Risk Management Plans (RMPs) Vigilance 9 21
A Regulatory Update on the Medical Device and In-Vitro Diagnostic Regulations in the EU and UK Regulatory Affairs 22 30
Advanced Pharmacovigilance Vigilance 18-20 9-13 24-26
Advanced Project Management in Clinical Research Clinical Research 4 11 9
Advanced Regulatory Affairs for Medical Devices Regulatory Affairs 7-8 13-14 3-4
Advanced Veterinary Pharmacovigilance Vigilance 9-10 13-14 24-25
An Essential Overview of Medical Information Regulatory Affairs 29 14
An Essential Overview of Pharmacovigilance Vigilance 9-10 27 15
An Essential Overview of the Medical Device Industry Regulatory Affairs 8 14
An Essential Overview of the Pharmaceutical and Biotech Industries Regulatory Affairs 13 16 12
An Introduction to Ethylene Oxide (EO) Sterilization for Medical Devices GxP 11 1
An Introduction to Human Factors for Pharmaceutical and Medical Device Professionals Regulatory Affairs 23 17
An Introduction to ISO 11607 - Packaging for Terminally Sterilized Medical Devices GxP 18 22
An Introduction to ISO 13485: 2016 - Quality Management System (QMS) for Medical Devices GxP 20 13
An Introduction to Pharmaceutical Packaging GxP 25-27 28-30 19-21
An Introduction to the Design and Development of Medical Devices Medical Technology 24-25 10-11 8-9
An Introduction to the Medical Device Regulation Regulatory Affairs 4-6 25-27
Animal Feed and Feed Additive Registration in China and Thailand Regulatory Affairs 16 27 26
Best Practice for Writing Effective SOPs Regulatory Affairs 12 27
Best Practices for Supplier Qualification in Life Science GxP 7-8 27-28
Biological Evaluation of Medical Devices Regulatory Affairs 16-17 15-16 15-16
Biosimilars Biopharma 1-2 30-31 21-22
Biotechnology for the Non-Biotechnologist Biopharma 25-27 2-6
CAPA (Corrective and Preventative Action) Regulatory Affairs 13 28
Chemistry, Manufacture and Control (CMC) - Regulatory Requirements for Biological Drug Products GxP 17-18 27-28 26-27
Cleaning Validation Best Practice in Pharmaceuticals GxP 5-6 8-9
Clinical Evaluation of Medical Device Software Clinical Research 18 22 13
Clinical Evaluation of Medical Devices: The Clinical Evaluation Report Clinical Research 27-28 31-3
Clinical Overview and Clinical Summary: Creating Effective Marketing Authorisation Application Regulatory Affairs 23-24 5-6 18-19
Clinical Quality Management Systems Clinical Research 19-20 23-24 22-23
Clinical Research Project Management Clinical Research 23-25 29-31 11-13
Clinical Trial Monitoring Clinical Research 29-30 2-3 28-29
Clinical Trial Regulatory Requirements Clinical Research 16-17 20-21 8-9
Cognitive Testing in Clinical Drug Trials: Successful Test Selection and Integration Clinical Research 12 19
Cosmetovigilance Vigilance 14-15 3-4 19-20
Cyber Security for Medical Devices Regulatory Affairs 15-16 28-29 8-9
Data Integrity Auditor Masterclass GxP 17-18 4-5 12-13
Data Integrity and Document Management GxP 6 7
Deep Dive into the IVDR Annex XIII Regulatory Affairs 5 5
Delivery of Biologics to the Nasal Cavity Biopharma 8
Development of Combination Products: Critical Interactions GxP 3-4 10-11 24-25
Drug Discovery: A Step-by-Step Introduction Medical Technology 23-24 23-24 8-9
EU Clinical Trial Regulation 536/2014: Overview and Implementation Experience Clinical Research 11-12 13-14 2-3
EU Pharmaceutical Regulations & Strategy Regulatory Affairs 14-15 10-11 9-10
EU Proposed Pharmaceutical Legislation Changes Regulatory Affairs 18 20 19
Effective Technical Writing & Editing Medical Writing 1 5 5
Effective Technology Transfer GxP 7-8 3-4 2-3
European Post Marketing Pharmacovigilance - Including the EMA/PRAC Deliberations and Brexit Implications Vigilance 4-8 3-7
FDA Approval Process for Medical Devices Regulatory Affairs 10-11 2-3 31-1
GCP and Clinical Research Update - Hot Inspection Topics Clinical Research 22 14
GMP Principles in Vaccine Manufacturing GxP 14-15 16-17
Global Pharmaceutical Regulatory Affairs Summer School Regulatory Affairs 9-13
Good Distribution Practices of Pharmaceuticals and APIs GxP 21-22 17-18
Human Factors and Usability Engineering in the Development of Drug Delivery Products Regulatory Affairs 17-20 5-6 15-16 13-14
ICH Q9(R1) Quality Risk Management (QRM) GxP 25 29 12
Introduction to Veterinary Pharmacovigilance Vigilance 2-3 10-11
Introduction to the In-Vitro Diagnostic Regulation (IVDR) Regulatory Affairs 5-8 5-6
Introduction to the New Performance Evaluation Requirements Mandated Under the IVDR (2017/746) Regulatory Affairs 4 4
Managing Competence within the Medical Device Industry Regulatory Affairs 5 26
Managing Service Providers including CRO and CMOs oversight to comply with ICH GCP R3 Clinical Research 17-18 6-7 23-24
Masterclass: Artificial Intelligence-based Medical Devices Medical Technology 26 7 5
Medical Device Regulation in the Eurasian Union, Russia and the CIS Regulatory Affairs 9-10 3-4
Medical Device Regulations in the Middle East and North Africa Regulatory Affairs 7-8 10-11
Medical Device Single Audit Programme (MDSAP) GxP 28-29 24-25
Medical Device Software: Complying with the EU MDR, EU IVDR & FDA Regulations Regulatory Affairs 22-25 18-21 11-14 24-27
Medical Device Studies: Clinical Evidence Clinical Research 11-12 17-18
Medical Device Studies: Regulatory Requirements and Adverse Event Reporting Clinical Research 16-19 15-16 7-8
Medical Writing for Medical Devices Medical Writing 21-22 12-13
Metered Dose Inhaler (MDI) Technology Medical Technology 9-10 24-27 19-20
Metrics and Earned Value in Clinical Research Projects Clinical Research 25 5
Navigating EU and FDA Regulations for Drug/Device and Device/Drug Combination Products Regulatory Affairs 17-18 21-22 19-20
New EU GMP Annex 1: Compliant Aseptic Operations GxP 26-28 11-13
Non-Conformance and Corrective Action for Medical Device Manufacturers Regulatory Affairs 12 10
Pharmaceutical Development of ATMPs GxP 14-15 3-4 17-18
Pharmaceutical Regulatory Affairs in Africa Regulatory Affairs 19-20 24-25 16-17
Pharmaceutical Regulatory Affairs in Asia Regulatory Affairs 9-11 25-27 11-13
Pharmaceutical Regulatory Affairs in China Regulatory Affairs 10-11 31-1 24-25
Pharmaceutical Regulatory Affairs in Latin America Regulatory Affairs 22 25 18
Pharmaceutical Regulatory Affairs in Russia and the Eurasian Union Regulatory Affairs 3-4 6-7 19-20
Pharmaceutical Regulatory Affairs in the Middle East Regulatory Affairs 9-10 25-26 23-24
Pharmacovigilance Vigilance 5-7 11-13
Pharmacovigilance Aspects of Licensing Agreements Vigilance 27-28 10
Pharmacovigilance QMS & Inspection Preparation Vigilance 26-27 20-21 19-20
Pharmacovigilance for Drug Safety, Regulatory Affairs and PV Auditors – Broadening your Knowledge Vigilance 30-2 29-31 7-9
Post-Market Surveillance - Practical Application for Medical Devices and IVDs Regulatory Affairs 10 12 5
Practical Implementation of GCP in Veterinary Field Studies GxP 26-27 14-15
Practical Implementation of a Human Factors Study Clinical Research 5-6 4-5
Practical Requirements of the Arab Pharmacovigilance Guidelines Vigilance 10-11 12-13
Pre-Filled Syringes: End-to-End Processing Medical Technology 6-7 20-21
Process Validation for Medical Devices GxP 15-16 25-26 5-6
Process Validation with Qualification GxP 23-24 13-14 20-21
Registration of Veterinary Pharmaceuticals in China Regulatory Affairs 16 27 26
Regulatory Affairs for Support Staff Regulatory Affairs 24-25 27-28 12-13
Regulatory Strategies for Orphan Drugs Regulatory Affairs 8 10 23
Risk Management for Pharma and Biopharma Professionals Regulatory Affairs 8 4 6
Signal Detection and Regulatory Expectations Vigilance 12-15 17-18
Smart Packaging and Electronic Patient Information GxP 4-5 13
Stability Testing of Pharmaceuticals and Biopharmaceuticals GxP 11-12 24-27
Sterilization of Medical Devices GxP 17-18 3-4 5-6
Successful Medical Writing – from Protocol to CTD Medical Writing 27-29
Sustainable Design and Manufacture for Medical Devices Medical Technology 4 24
The Animal Health Summer School: Working Through Veterinary Drug Development in the EU and USA Regulatory Affairs 16-19
The Common Technical Document GxP 25-26 11-12
The Common Technical Document (CTD) Submission in the MENA Region Regulatory Affairs 28 13
The FDA Drug Approval Process Regulatory Affairs 2-3 24-25 11-12
The Medical Device School - From Concept to CE Marking Regulatory Affairs 2-6 9-13
The Role of the Person Responsible for Regulatory Compliance (PRRC) Under the MDR and IVDR Regulatory Affairs 24 23 22
Thinking Outside of the GMP Box GxP 10-11 14-15 13-14
UK Conformity Assessed (UKCA) Marking for Medical Devices Regulatory Affairs 19 10 26
US FDA - Understanding Key Factors When Working with the FDA Biopharma 27 13
Understanding Active Pharmaceutical Ingredients (APIs) GxP 18-19 25-26
Understanding Computer System Validation (CSV) GxP 24-25 4-5 18-19
Understanding Pharmacovigilance Regulations in APAC Vigilance 8-9 13-14 16-17
Unique Device Identification (UDI) and Labelling for Medical Device Manufacturers Regulatory Affairs 5 24
Variations to Marketing Authorisations Regulatory Affairs 28-29 6-7 3-4
Veterinary Pharmaceutical Submissions in the EU Regulatory Affairs 26-27 19-20